ELV Elevance Health Inc

$348.87

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-12-31
Expected on Jan 28, 2026
Report Time: Before the Bell
The Whisper Number
$2.85
Consensus Estimate: $3.11
Revenue Estimate: $49.71B

Latest Earnings Insight

Elevance Health's upcoming earnings report on October 21 is set against a backdrop of anticipation, particularly as the company navigates the evolving healthcare landscape. With an EPS estimate of $4.94 and a revenue projection of $49.34 billion, the market is keenly observing how Elevance will perform relative to the whisper number of $4.98, which subtly raises the bar for expectations. Despite the absence of recent news, Elevance's substantial market cap of approximately $79.5 billion underscores its significant presence in the industry. Investors will be looking for signs of strategic initiatives that could drive future growth, especially in light of the company's historical performance and the broader market sentiment towards healthcare providers. As the earnings date approaches, the focus will be on whether Elevance can exceed these expectations and deliver results that reflect both operational efficiency and strategic foresight.

Updated On 1/6/2026

About Elevance Health Inc

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Website: https://www.elevancehealth.com

Sector
FINANCE
Industry
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1156039
Address
120 MONUMENT CIRCLE, INDIANAPOLIS, IN, US
Valuation
Market Cap
$96.11B
P/E Ratio
16.53
PEG Ratio
0.76
Price to Book
2.33
Performance
EPS
$25.68
Dividend Yield
1.61%
Profit Margin
3.38%
ROE
14.80%
Technicals
50D MA
$414.38
200D MA
$450.86
52W High
$560.90
52W Low
$360.70
Fundamentals
Shares Outstanding
226M
Target Price
$501.23
Beta
0.78

ELV EPS Estimates vs Actual

Estimated
Actual

ELV News & Sentiment

Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Generate Investment Management Ltd Has $43.62 Million Holdings in Elevance Health, Inc. $ELV
Generate Investment Management Ltd significantly increased its stake in Elevance Health, Inc. (NYSE:ELV) by 37.7% during the third quarter, bringing its total holdings to 135,000 shares valued at $43.62 million. This move positions Elevance Health as the 10th largest holding in Generate Investment Management Ltd's portfolio. Other institutional investors have also adjusted their positions, and analysts have issued varied ratings, with a consensus "Hold" and an average target price of $396.21.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Brookstone Capital Management Sells 8,259 Shares of Elevance Health, Inc. $ELV
Brookstone Capital Management significantly reduced its stake in Elevance Health (NYSE:ELV) by 80.2%, selling 8,259 shares but retaining 2,040 shares valued at $659,000. Elevance Health exceeded Q3 expectations with EPS of $6.03 and revenues of $50.09 billion, while also declaring a quarterly dividend of $1.71. Analysts currently maintain a "Hold" rating for the stock with an average price target of $396.21.
Dec 30, 2025 • The Globe and Mail NEUTRAL
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
This article compares UnitedHealth Group (UNH) and Elevance Health (ELV), two major players in the U.S. managed healthcare sector. While UNH, the largest insurer, benefits from its diversified Optum segment, it faces challenges from rising medical costs and regulatory scrutiny. ELV, despite also facing cost pressures, presents a stronger near-term risk-reward profile due to strategic exits from underperforming markets, the growth of its Carelon platform, and a more appealing valuation.
Dec 30, 2025 • TradingView — Track All Markets NEUTRAL
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
UnitedHealth Group (UNH) and Elevance Health, Inc. (ELV) are major players in the U.S. managed healthcare sector, both facing challenges from rising medical costs and regulatory scrutiny. While UNH boasts significant scale and its diversified Optum segment, it is dealing with margin pressures and regulatory investigations. ELV, however, appears to be in a stronger near-term position due to strategic market exits, the growth of its Carelon platform, and a more attractive valuation for investors.
Dec 30, 2025 • Stocktwits NEUTRAL
Is Molina Healthcare The Next GEICO? Michael Burry Feels It's A ‘Special One’
Michael Burry, known for "The Big Short," has taken a long position in Molina Healthcare (MOH), likening it to an early-stage GEICO. Despite the company's recent struggles with slowing revenue growth and thin margins, Burry sees Molina as a "special one" with a clearer path to long-term earnings growth than many large-cap peers, even suggesting Warren Buffett would invest in it if he were younger and scaling his insurance investments. Analysts, however, mostly maintain neutral ratings, seeing limited upside for the stock.
Dec 30, 2025 • Benzinga SOMEWHAT-BULLISH
Looking Into Centene Corp's Recent Short Interest
Centene Corp's (NYSE: CNC) short interest has decreased by 6.98% since its last report, with 12.59 million shares currently sold short, representing 2.93% of available shares. It would take traders an average of 1.97 days to cover their short positions. Compared to its peers, Centene Corp has less short interest, indicating a potentially more bullish sentiment from investors.
Sentiment Snapshot

Average Sentiment Score:

0.051
50 articles with scored sentiment

Overall Sentiment:

Neutral

ELV Reported Earnings

Jul 17, 2025
Jun 30, 2025 (Pre market)
-0.82 Surprise
  • Reported EPS: $7.72
  • Estimate: $8.54
  • Whisper:
  • Surprise %: -9.6%
Apr 22, 2025
Mar 31, 2025 (Pre market)
0.49 Surprise
  • Reported EPS: $11.97
  • Estimate: $11.48
  • Whisper:
  • Surprise %: 4.3%
Jan 23, 2025
Dec 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $3.84
  • Estimate: $3.85
  • Whisper:
  • Surprise %: -0.3%
Oct 17, 2024
Sep 30, 2024 (Pre market)
-1.28 Surprise
  • Reported EPS: $8.37
  • Estimate: $9.65
  • Whisper:
  • Surprise %: -13.3%
Jul 17, 2024
Jun 30, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.12
  • Estimate: $10.01
  • Whisper:
  • Surprise %: 1.1%
Apr 18, 2024
Mar 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.64
  • Estimate: $10.53
  • Whisper:
  • Surprise %: 1.0%
Jan 24, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $5.62
  • Estimate: $5.59
  • Whisper:
  • Surprise %: 0.5%
Oct 18, 2023
Sep 30, 2023 (Pre market)
0.53 Surprise
  • Reported EPS: $8.99
  • Estimate: $8.46
  • Whisper:
  • Surprise %: 6.3%
Jul 19, 2023
Jun 30, 2023 (Pre market)
0.26 Surprise
  • Reported EPS: $9.04
  • Estimate: $8.78
  • Whisper:
  • Surprise %: 3.0%

Financials